Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation

被引:22
作者
Marz, W
Scharnagl, H
Kirca, M
Bohl, J
Gross, W
Ohm, TG
机构
[1] UNIV MAINZ,DEPT NEUROPATHOL,W-6500 MAINZ,GERMANY
[2] UNIV FRANKFURT,GUSTAV EMBDEN CTR BIOL CHEM,W-6000 FRANKFURT,GERMANY
[3] CHARITE,INST ANAT,BERLIN,GERMANY
来源
NEUROBIOLOGY OF ALZHEIMER'S DISEASE | 1996年 / 777卷
关键词
D O I
10.1111/j.1749-6632.1996.tb34432.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent work provided evidence that the apolipoprotein (ape) E polymorphism is associated with late-onset sporadic Alzheimer's disease. The major histological hallmarks of Alzheimer's disease are the extraneuronal deposition of A4/beta-amyloid and the intraneuronal formation of neurofibrillary tangles, the latter correlating strongly with the psychometric status. We examined the relationship between the apo E polymorphism and Alzheimer's disease-related histological changes using a staging system which accounts for the progression of the disease over time and correlates well with the cognitive decline ante mortem. We observed a significant positive correlation between both neurofibrillary changes and A4/beta-amyloid deposits and the epsilon 4 gene dose. We estimated that the presence of one apo E4 allele leads to an earlier onset of the histopathological process of about one decade. The association of both types of Alzheimer's disease-related changes with the prevalence of the epsilon 4-allele suggests that the apo E polymorphism causally contributes to the development of Alzheimer's disease.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 16 条
[1]   NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
GROWDON, JH ;
HEDLEYWHYTE, ET ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (03) :631-639
[2]   ALZHEIMERS-DISEASE - MISMATCH BETWEEN AMYLOID PLAQUES AND NEURITIC PLAQUES [J].
BRAAK, H ;
BRAAK, E ;
OHM, T ;
BOHL, J .
NEUROSCIENCE LETTERS, 1989, 103 (01) :24-28
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]  
BRAAK H, 1992, ADV CLIN BASIC RES, P131
[5]  
CAMPBELL S, 1989, SOC NEUR ABSTR, V13, P678
[6]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[7]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[8]  
GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1
[9]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[10]   CLOSE-MESHED PREVALENCE RATES OF DIFFERENT STAGES AS A TOOL TO UNCOVER THE RATE OF ALZHEIMERS DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
OHM, TG ;
MULLER, H ;
BRAAK, H ;
BOHL, J .
NEUROSCIENCE, 1995, 64 (01) :209-217